Abstract 2320: Clinical epigenetic resensitization of platinum-resistant, recurrent ovarian cancer patients with SGI-110, a novel, second-generation, subcutaneously administered hypomethylating agent (HMA)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fleming, G; Ghamande, S; Lin, Y; Secord, AA; Nemunaitis, J; Markham, M-J; Nephew, K; Fang, F; Gupta, S; Naim, S; Choy, G; Jueliger, S; Taverna, P; Hao, Y; Keer, H; Azab, M; Matei, D

Published Date

  • October 1, 2014

Published In

  • Molecular and Cellular Biology

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2014-2320

Conference Name

  • Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA